Santhera Pharmaceuticals’ CHF 20 Million Shares Private Placement

Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera.Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular and…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now